Papa Leão XIV deve ser submetido a imunoterapia para prevenir volta de câncer

Pope Leo XIV is expected to receive pembrolizumab immunotherapy for at least three years following surgery to remove a lung adenocarcinoma, according to sources at Rome's Gemelli Hospital. The Vatican had previously said he would not receive additional cancer treatment; the pope is recovering and canceled a planned visit to Assisi.